Terms: = Head and neck cancer AND BCL11B, CTIP-2, 64919, ENSG00000127152, CTIP2, hRIT1-alpha, Q9C0K0
3 results:
1. Discrimination of cancer Stem Cell Markers ALDH1A1, bcl11b, BMI-1, and CD44 in Different Tissues of HNSCC Patients.
Sharaf K; Lechner A; Haider SP; Wiebringhaus R; Walz C; Kranz G; Canis M; Haubner F; Gires O; Baumeister P
Curr Oncol; 2021 Jul; 28(4):2763-2774. PubMed ID: 34287293
[TBL] [Abstract] [Full Text] [Related]
2. Role of cancer stem cell markers ALDH1, bcl11b, BMI-1, and CD44 in the prognosis of advanced HNSCC.
Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
[TBL] [Abstract] [Full Text] [Related]
3. ctip2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract] [Full Text] [Related]
